Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AxioMed Spine financings

This article was originally published in The Gray Sheet

Executive Summary

The degenerative spine disease start-up completed a "series D" funding round, collecting $14.5 million from existing and new investors, AxioMed announced July 22. The privately-held company plans to use the funds to complete enrollment of a U.S. pivotal study for its Freedom lumbar disc, which has a CE mark in Europe and has been sold there for the past 12 months. The investment will also help AxioMed expand its sales force for Freedom in Europe, as well as achieve CE mark and support the launch of its cervical disc
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT029186

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel